Proteins belonging to the BcL-2 family and fragments thereof, and their use in cancer patients

Details for Australian Patent Application No. 2004290866 (hide)

Owner Survac ApS

Inventors Straten, Eivind Per Thor; Andersen, Mads Hald

Agent Peter Maxwell & Associates

Pub. Number AU-B-2004290866

PCT Pub. Number WO2005/049073

Priority PA 2003 01716 19.11.03 DK; 60/523,119 19.11.03 US

Filing date 18 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 2 September 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/049073 Priority application(s): WO2005/049073

2 September 2010 Application Accepted

  Published as AU-B-2004290866

6 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290868-A method and process for controlling the temperature, pressure-and density profiles in dense fluid processes

2004290862-Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices